Personal information

Molecular Pathology, Surgical Pathology, GPCR, G-coupled protein receptors, Ovarian Cancer, Gastrointestinal Cancer, Pancreatic Cancer, Cholangiocarcinoma, Cell Signaling, Cancer, Pancreatobiliary cancer, GI pathology, Liver pathology, SARS-CoV-2, COVID-19, Immunology, LPA, Lysophosphatidic acid
United States

Activities

Employment (3)

Duke University: Durham, US

2024-07-01 to 2025-06-30 | Molecular Genetic Pathology Fellow (Pathology)
Employment
Source: Self-asserted source
Jeremy D. Ward

Duke University: Durham, US

2023-07-01 to 2024-06-30 | GI/Liver/Pancreas Surgical Pathology Fellow (Surgical Pathology)
Employment
Source: Self-asserted source
Jeremy D. Ward

University of North Carolina Hospitals: Chapel Hill, North Carolina, US

2019-07-01 to 2023-06-30 | Resident (Pathology)
Employment
Source: Self-asserted source
Jeremy D. Ward

Education and qualifications (2)

The University of Oklahoma College of Medicine: Oklahoma City, OK, US

2017-05 | MD
Education
Source: Self-asserted source
Jeremy D. Ward

The University of Oklahoma Health Sciences Center: Oklahoma City, OK, US

2013-07 | PhD (Cell Biology)
Education
Source: Self-asserted source
Jeremy D. Ward

Works (14)

PD-L1 expression in pancreaticobiliary adenosquamous carcinoma: a single-institution case series

Journal of Gastrointestinal Oncology
2024 | Journal article
EID:

2-s2.0-85192863775

Part of ISSN: 2219679X 20786891
Contributors: Ward, J.D.; Fowler, M.; Robledo-Gomez, A.; Goodyear, S.M.; Kardosh, A.; Sasatomi, E.
Source: Self-asserted source
Jeremy D. Ward via Scopus - Elsevier
grade
Preferred source (of 2)‎

Impact of the COVID-19 pandemic: SARS-CoV-2-specific IgG antibodies and their vertical transfer

International and Life Course Aspects of COVID-19
2024-06-13 | Book chapter
Contributors: Jeremy D. Ward
Source: Self-asserted source
Jeremy D. Ward

Small duct type intrahepatic cholangiocarcinoma with extensive intraductal extension mimics an intraductal tubulopapillary neoplasm

Human Pathology Reports
2023 | Journal article
EID:

2-s2.0-85144425512

Part of ISSN: 2772736X
Contributors: Fowler, M.; Ward, J.D.; Hertel, J.D.; Sasatomi, E.
Source: Self-asserted source
Jeremy D. Ward via Scopus - Elsevier

The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies

medRxiv
2022 | Other
EID:

2-s2.0-85127369343

Contributors: Ward, J.D.; Cornaby, C.; Kato, T.; Gilmore, R.C.; Bunch, D.; Miller, M.B.; Boucher, R.C.; Schmitz, J.L.; Askin, F.A.; Scanga, L.R.
Source: Self-asserted source
Jeremy D. Ward via Scopus - Elsevier

The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies.

Placenta
2022-05-01 | Journal article
Source: Self-asserted source
Jeremy D. Ward
grade
Preferred source (of 2)‎

Longitudinal SARS-CoV-2 Testing among the Unvaccinated Is Punctuated by Intermittent Positivity and Variable Rates of Increasing Cycle Threshold Values.

Microbiology spectrum
2022-03-22 | Journal article
Source: Self-asserted source
Jeremy D. Ward
grade
Preferred source (of 2)‎

Beyond the Syndrome: Extensive Congenital Abnormalities in an Infant With Trisomy 21.

Clinical pathology (Thousand Oaks, Ventura County, Calif.)
2022-01-01 | Journal article
Source: Self-asserted source
Jeremy D. Ward
grade
Preferred source (of 2)‎

Longitudinal SARS-CoV-2 testing is punctuated by intermittent positivity and variable rates of cycle-threshold decline

medRxiv
2021 | Other
EID:

2-s2.0-85119391211

Contributors: Hawken, S.E.; Sellers, S.A.; Smedberg, J.R.; Ward, J.D.; Whinna, H.C.; Fischer, W.; Miller, M.B.
Source: Self-asserted source
Jeremy D. Ward via Scopus - Elsevier

Indeterminate QuantiFERON Gold Plus results reveal deficient IFN-γ responses in severely ill COVID-19 patients.

Journal of clinical microbiology
2021-07-07 | Journal article
Source: Self-asserted source
Jeremy D. Ward
grade
Preferred source (of 2)‎

LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response.

Cancer research
2018-01-31 | Journal article
Source: Self-asserted source
Jeremy D. Ward
grade
Preferred source (of 2)‎

Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.

Oncotarget
2016-06-01 | Journal article
Source: Self-asserted source
Jeremy D. Ward
grade
Preferred source (of 2)‎

LPA-mediated migration of ovarian cancer cells involves translocalization of Gαi2 to invadopodia and association with Src and β-pix.

Cancer letters
2014-10-13 | Journal article
Source: Self-asserted source
Jeremy D. Ward
grade
Preferred source (of 2)‎

The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.

Cellular signalling
2013-09-19 | Journal article
Source: Self-asserted source
Jeremy D. Ward
grade
Preferred source (of 2)‎

LPA Stimulates the Phosphorylation of p130Cas via Gαi2 in Ovarian Cancer Cells.

Genes & cancer
2012-09-01 | Journal article
Source: Self-asserted source
Jeremy D. Ward
grade
Preferred source (of 2)‎